Hamza Suria, M.Sc., M.B.A.
President & CEO
Mr. Suria joined AnaptysBio in December 2008. Prior to AnaptysBio, Mr. Suria was at Maxygen, where he was responsible for partnering and alliance management of next-generation protein therapeutics with Roche, Sanofi-Aventis, Bayer, Astellas and others. Before Maxygen, Mr. Suria was responsible for business development at Diabetogen Biosciences and Viron Therapeutics. Suria holds a B.Sc. in biochemistry from Kalamazoo College, an M.S. in immunology from the University of Western Ontario and an Executive MBA from the Richard Ivey School of Business.
David J. King, Ph.D.
Chief Scientific Officer
Dr. King joined AnaptysBio in November 2008. Prior to AnaptysBio, Dr. King was at Medarex, where he was involved in the design and selection of therapeutic antibodies, and led the development of a new class of antibody-drug conjugates. Dr. King is an established expert in antibody engineering and antibody therapeutics and has been involved in the design and development of three FDA-approved antibody products and several other clinical stage antibodies. At Celltech in the UK, where he worked for 14 years, he was the lead inventor of Cimzia®, a PEGylated antibody fragment for therapy of autoimmune diseases and was involved in the design and development of Mylotarg®, an antibody-drug conjugate for therapy of acute myeloid leukemia. Prior to joining Medarex, Dr. King was at Coulter Pharmaceuticals, later acquired by Corixa, where he was part of the team which successfully refiled the BLA for Bexxar®, a radiolabelled antibody for therapy of non-Hodgkin’s lymphoma. Dr. King received his B.S. from the University of Warwick and his Ph.D. from the University of Surrey in the U.K., and was a Glaxo Group Research postdoctoral fellow.
Ed O’Sullivan, M.B.A.
Chief Financial Officer (Consultant)
Ed O’Sullivan joined AnaptysBio as CFO Consultant in December 2007. Prior to AnaptysBio, Ed has served in the capacity of Chief Financial Officer for a number of start-up and Fortune 50 companies, including Electron, Inc., Fluid Systems -Allied-Signal, Inc., Newpoint Corporation - Proxima Corporation and Nextec Applications, Inc. Ed is currently serving on the Board of Directors of LetsGoRobotics, Inc. Ed has a BA degree from the University of California, San Diego, Revelle College, an MBA degree from the University of San Diego and has completed Executive Education courses in Corporate Governance at Harvard Business School.